We’re Prescribing the Wrong First Treatment

Key Takeaways

• Exercise matches antidepressants for mild-to-moderate depression.
• Exercise lowers relapse rates compared with medication alone.
• Combining exercise with meds improves outcomes over single treatments.
• SMILE trial and 2024 BMJ meta‑analysis validate exercise efficacy.
• Current guidelines often overlook exercise as first‑line therapy.

Pulse Analysis

Teen depression rates are climbing, and clinicians frequently reach for antidepressants as the default solution. While medication can be life‑saving, the evidence base now shows that structured aerobic activity, yoga, or strength training delivers comparable symptom relief for mild‑to‑moderate cases. Studies such as the SMILE trial, which randomized participants to exercise, sertraline, or both, found similar remission after four months but a markedly lower relapse rate for the exercise‑only group. A 2024 BMJ network meta‑analysis of over 200 trials reinforced these findings, reporting moderate‑to‑large effect sizes for walking, jogging, and yoga—sometimes surpassing the modest gains seen with SSRIs.

Beyond mental health scores, exercise confers tangible physical benefits that medications lack. Running therapy trials documented identical remission rates to antidepressants while improving weight, blood pressure, and heart‑rate variability. Meta‑analyses of adjunctive exercise consistently show added effect sizes of around 0.6 standard deviations when paired with standard care, especially in more severe depression. The dose‑response relationship suggests 13‑36 supervised sessions yield optimal outcomes, with moderate‑intensity workouts offering the greatest benefit. Although methodological limitations exist—blinding is impossible and many studies rely on self‑report—the convergence of findings across diverse designs strengthens the case for exercise as a credible therapeutic option.

For providers, insurers, and policymakers, the implication is clear: prescribing movement should become as routine as prescribing a medication. Integrating a 30‑minute, five‑days‑a‑week exercise plan into initial treatment protocols could curb unnecessary drug exposure, reduce relapse risk, and promote holistic health. Overcoming barriers—such as limited reimbursement for lifestyle counseling and patient adherence challenges—will require updated clinical guidelines, reimbursement models that reward preventive care, and digital tools to monitor activity. By rebalancing the treatment hierarchy, the healthcare system can address teen depression more effectively while leveraging a low‑cost, high‑impact intervention that benefits both mind and body.